Skip to main content

IPO Chilli Ratings

IPO Chilli Ratings
Click to understand how it works

Featured

Singapore Institute of Advanced Medicine Holdings Ltd

Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist.  The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am.   Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases.  SAM has strategic collaborations with public and private institutions for research and clinical work.  SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi

Hyflux Water Trust



Hyflux Water Trust is the first pure-play global water business trust to be listed on a securities exchange in Sia that provides investors with an opportunity to invest in water-related infrastructure asset in China, Middle East and North Africa region. Upon listing, it will have 13 plants in China.

Sponsor: Hyflux
Number of Units : 165 million (Out of which 30m for Public, 135m for Placement)
Price per Unit: $0.78
Yield 5.72% for FY 2008 (after Sponsor waived off its rights to the Distributions)
Yield 6.74% for FY 2009

In my personal view, this is one of the smartest strategic move by one of the richest lady in Singapore. Hyflux, with its expertise in Water Treatment, owns many water treatment plants. The setting up of the Trust allows Hyflux to 'cash out' of its fixed assets by selling these assets to the Trust in exchange for Units and enticing investors with the 'yield' carrot. To me, the yield presented in the prospectus is unlikely to be achieved if not for the Sponsor waiving off its rights to the distributions in FY2008 and most likely in FY2009, it will elect to receive its management fees in units in order to meet the yield projections. To me, the entire exercise benefits Hyflux the most as it will allow Hyflux to recycle its capital and cash out on its assets.

The closest peer listed in Singapore is Cityspring but at least the performance fee of Hyflux will not be based on its share price performance. Although i like the business in which it is in, the yield presented in the Prospectus is really too low for me vis-a-vis the risks involved. The "Sponsor" might be a better investment target that the Trust. Anyway, my personal view is not to subscribe to the IPO. If you really need that yield, a property trust might just do the trick and the share price performance of Cityspring post its listing isnt helping either.

Comments